Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Measuring the prognostic impact of ferritin levels in myelodysplastic syndrome patients: the role of susceptibility biases
-
Article
IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: A case report
The frequency of monoclonal gammopathy of undetermined significance (MGUS) is higher in patients with type I Gaucher disease (GD I) than in the general population. Although enzyme replacement therapy is effect...